{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:00:57Z","timestamp":1791928857337,"version":"4.3.4"},"reference-count":50,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"DOI":"10.1167\/iovs.66.6.2","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T10:30:39Z","timestamp":1748860239000},"page":"2","source":"Crossref","is-referenced-by-count":1,"title":["Several Common Genetic Variations Associate With Functional or Anatomic Effects of Anti-VEGF Treatment in Conditions With Macular Edema"],"prefix":"10.1167","volume":"66","author":[{"given":"Ingeborg","family":"Klaassen","sequence":"first","affiliation":[{"name":"Ocular Angiogenesis Group, Department of Ophthalmology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Microcirculation, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"},{"name":"Cellular & Molecular Mechanisms, Amsterdam Neuroscience, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje J. C.","family":"Vader","sequence":"additional","affiliation":[{"name":"Ocular Angiogenesis Group, Department of Ophthalmology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Aissa","sequence":"additional","affiliation":[{"name":"Ocular Angiogenesis Group, Department of Ophthalmology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W. T.","family":"Tanck","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier O.","family":"Schlingemann","sequence":"additional","affiliation":[{"name":"Ocular Angiogenesis Group, Department of Ophthalmology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Microcirculation, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands"},{"name":"Cellular & Molecular Mechanisms, Amsterdam Neuroscience, Amsterdam, The Netherlands"},{"name":"Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the BRAMD, BRVO, and BRDME Study Groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"bib3","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s00125-016-3974-8","article-title":"Diabetic macular oedema: pathophysiology, management challenges and treatment resistance","volume":"59","author":"Bahrami","year":"2016","journal-title":"Diabetologia"},{"issue":"8","key":"bib4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/jamaophthalmol.2018.2019","article-title":"Association of genetic variants with response to anti-vascular endothelial growth factor therapy in age-related macular degeneration","volume":"136","author":"Lor\u00e9s-Motta","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"14","key":"bib5","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.1167\/iovs.16-20157","article-title":"Association of circulating markers with outcome parameters in the bevacizumab and ranibizumab in diabetic macular edema trial","volume":"57","author":"Fickweiler","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"bib6","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3390\/jpm11121297","article-title":"miRNA levels as a biomarker for anti-VEGF response in patients with diabetic macular edema","volume":"11","author":"Vader","year":"2021","journal-title":"J Pers Med"},{"issue":"12","key":"bib7","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1136\/bjophthalmol-2016-308388","article-title":"Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature","volume":"100","author":"Ashraf","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"bib8","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.3390\/ijms23074042","article-title":"Identifying genetic biomarkers predicting response to anti-vascular endothelial growth factor injections in diabetic macular edema","volume":"23","author":"Gurung","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"bib9","doi-asserted-by":"publisher","first-page":"e0153052","DOI":"10.1371\/journal.pone.0153052","article-title":"Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration. The BRAMD study","volume":"11","author":"Schauwvlieghe","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"bib10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.oret.2019.12.019","article-title":"Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a randomized trial","volume":"4","author":"Vader","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"bib11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.oret.2020.02.008","article-title":"Comparing the efficacy of bevacizumab and ranibizumab in patients with diabetic macular edema (BRDME): the BRDME study, a randomized trial","volume":"4","author":"Vader","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"24","key":"bib12","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/bioinformatics\/bts610","article-title":"GWASTools: an R\/Bioconductor package for quality control and analysis of genome-wide association studies","volume":"28","author":"Gogarten","year":"2012","journal-title":"Bioinformatics"},{"issue":"1","key":"bib13","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","article-title":"Functional mapping and annotation of genetic associations with FUMA","volume":"8","author":"Watanabe","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"bib14","doi-asserted-by":"publisher","first-page":"22527","DOI":"10.1038\/s41598-022-26048-7","article-title":"Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection","volume":"12","author":"Hong","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"bib15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ophtha.2013.10.047","article-title":"Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration","volume":"121","author":"Hermann","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"bib16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1159\/000508902","article-title":"Relationship between aflibercept efficacy and genetic variants of genes associated with neovascular age-related macular degeneration: the BIOIMAGE trial","volume":"243","author":"Bur\u00e9s Jelstrup","year":"2020","journal-title":"Ophthalmologica"},{"issue":"1","key":"bib17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/FPC.0000000000000180","article-title":"A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration","volume":"26","author":"Lor\u00e9s-Motta","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"37924","DOI":"10.1038\/srep37924","article-title":"GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration","volume":"6","author":"Riaz","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"bib19","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.ophtha.2015.05.004","article-title":"Common sequence variation in the VEGFC gene is associated with diabetic retinopathy and diabetic macular edema","volume":"122","author":"Kaidonis","year":"2015","journal-title":"Ophthalmology"},{"issue":"12","key":"bib20","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1167\/iovs.09-3694","article-title":"Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy","volume":"50","author":"Abhary","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"bib21","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s10792-017-0738-5","article-title":"VEGF \u2013 a gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema","volume":"38","author":"Tetikoglu","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"1","key":"bib22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archophthalmol.2009.355","article-title":"Association between erythropoietin gene polymorphisms and diabetic retinopathy","volume":"128","author":"Abhary","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"bib23","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.2337\/diacare.27.9.2184","article-title":"Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes","volume":"27","author":"Awata","year":"2004","journal-title":"Diabetes Care"},{"issue":"8","key":"bib24","doi-asserted-by":"publisher","first-page":"e1010609","DOI":"10.1371\/journal.pgen.1010609","article-title":"Multi-ancestry GWAS analysis identifies two novel loci associated with diabetic eye disease and highlights APOL1 as a high risk locus in patients with diabetic macular edema","volume":"19","author":"Stockwell","year":"2023","journal-title":"PLoS Genet"},{"issue":"8","key":"bib25","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1007\/s11033-021-06581-w","article-title":"The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics","volume":"48","author":"Dlouha","year":"2021","journal-title":"Mol Biol Rep"},{"issue":"2","key":"bib26","doi-asserted-by":"publisher","first-page":"110286","DOI":"10.1016\/j.ygeno.2022.110286","article-title":"The Human Eye Transcriptome Atlas: a searchable comparative transcriptome database for healthy and diseased human eye tissue","volume":"114","author":"Wolf","year":"2022","journal-title":"Genomics"},{"issue":"7538","key":"bib27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"issue":"12","key":"bib28","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1038\/oby.2012.162","article-title":"Copy number variations associated with obesity-related traits in African Americans: a joint analysis between GENOA and HyperGEN","volume":"20","author":"Zhao","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"881633","DOI":"10.3389\/fendo.2022.881633","article-title":"A genome-wide association study of prediabetes status change","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"bib30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nrc2459","article-title":"The ADAMs: signalling scissors in the tumour microenvironment","volume":"8","author":"Murphy","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"bib31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.semcdb.2008.11.002","article-title":"The \u201ca disintegrin and metalloprotease\u201d (ADAM) family of sheddases: physiological and cellular functions","volume":"20","author":"Reiss","year":"2009","journal-title":"Semin Cell Dev Biol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"12796","DOI":"10.1038\/srep12796","article-title":"ADAM12 and ADAM17 are essential molecules for hypoxia-induced impairment of neural vascular barrier function","volume":"5","author":"Cui","year":"2015","journal-title":"Sci Rep"},{"issue":"5","key":"bib33","doi-asserted-by":"publisher","first-page":"H790","DOI":"10.1152\/ajpheart.00803.2014","article-title":"ADAM12: a genetic modifier of preclinical peripheral arterial disease","volume":"309","author":"Dokun","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"bib34","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1074\/jbc.M110.180489","article-title":"Endothelial argininosuccinate synthetase 1 regulates nitric oxide production and monocyte adhesion under static and laminar shear stress conditions","volume":"286","author":"Mun","year":"2011","journal-title":"J Biol Chem"},{"issue":"5","key":"bib35","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/ajmg.a.38652","article-title":"Van Maldergem syndrome and Hennekam syndrome: further delineation of allelic phenotypes","volume":"176","author":"Ivanovski","year":"2018","journal-title":"Am J Med Genet A"},{"issue":"6","key":"bib36","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1172\/JCI99027","article-title":"Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow","volume":"130","author":"Betterman","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"bib37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000331721","article-title":"Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy","volume":"28","author":"Pfister","year":"2011","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"bib38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.bbalip.2011.06.028","article-title":"Subcellular localization and regulation of StarD4 protein in macrophages and fibroblasts","volume":"1811","author":"Rodriguez-Agudo","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"bib39","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/ijms25021004","article-title":"Inherited retinal degeneration caused by dehydrodolichyl diphosphate synthase mutation \u2013 effect of an ALG6 modifier variant","volume":"25","author":"Monson","year":"2024","journal-title":"Int J Mol Sci"},{"key":"bib40","first-page":"1740","article-title":"Analysis of FOXD3 sequence variation in human ocular disease","volume":"18","author":"Kloss","year":"2012","journal-title":"Mol Vis"},{"issue":"6","key":"bib41","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.3390\/ijms25063446","article-title":"Integrative kinase activity profiling and phosphoproteomics of rd10 mouse retina during cGMP-dependent retinal degeneration","volume":"25","author":"Roy","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"bib42","doi-asserted-by":"publisher","first-page":"e001081","DOI":"10.1161\/JAHA.112.001081","article-title":"CaMK4 gene deletion induces hypertension","volume":"1","author":"Santulli","year":"2012","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"bib43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00417-003-0828-0","article-title":"Role of growth factors and the wound healing response in age-related macular degeneration","volume":"242","author":"Schlingemann","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"bib44","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.3390\/ijms23116094","article-title":"Genetic association analysis of anti-VEGF treatment response in neovascular age-related macular degeneration","volume":"23","author":"Strunz","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"bib45","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.3390\/ijms24054676","article-title":"Interleukin-6 and macular edema: a review of outcomes with inhibition","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"bib46","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s12035-019-01844-x","article-title":"Sphingosine 1-phosphate signaling is involved in impaired blood\u2013brain barrier function in ischemia-reperfusion injury","volume":"57","author":"Nakagawa","year":"2020","journal-title":"Mol Neurobiol"},{"issue":"9","key":"bib47","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/bjophthalmol-2021-319115","article-title":"Sphingosine 1-phosphate, a potential target in neovascular retinal disease","volume":"106","author":"Alshaikh","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"bib48","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s001250051200","article-title":"Increased expression of endothelial antigen PAL-E in human diabetic retinopathy correlates with microvascular leakage","volume":"42","author":"Schlingemann","year":"1999","journal-title":"Diabetologia"},{"issue":"4","key":"bib49","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.ajpath.2015.11.019","article-title":"Plasmalemma vesicle-associated protein has a key role in blood\u2013retinal barrier loss","volume":"186","author":"Wisniewska-Kruk","year":"2016","journal-title":"Am J Pathol"},{"issue":"1","key":"bib50","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12987-018-0109-2","article-title":"The role of plasmalemma vesicle-associated protein in pathological breakdown of blood\u2013brain and blood\u2013retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema","volume":"15","author":"Bosma","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"bib2","article-title":"VA evidence-based synthesis program reports","volume-title":"Comparative Clinical and Economic Effectiveness of Anti-vascular Endothelial Growth Factor Agents","author":"Low","year":"2017"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:59Z","timestamp":1791927119000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2803048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.6.2","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,2]]}}}